SPRR3 | Small proline-rich protein 3 | Cancer-related genes
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/44467/144094_B_8_1_rna_selected_60x60.jpg) | Group enriched |
CNFN | Cornifelin | | | ![](/images/53997/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/49073/110082_B_8_4_rna_selected_60x60.jpg) | Group enriched |
SPINK5 | Serine peptidase inhibitor, Kazal type 5 | Disease related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/9067/ihc_cell_selected_60x60.jpg) | ![](/images/9067/24812_B_9_4_rna_selected_60x60.jpg) | Group enriched |
SPRR1A | Small proline-rich protein 1A | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/11237/120268_B_9_2_rna_selected_60x60.jpg) | Group enriched |
RPTN | Repetin | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/30485/144258_A_2_1_rna_selected_60x60.jpg) | Group enriched |
RHCG | Rh family, C glycoprotein | Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/41874/86782_B_4_2_rna_selected_60x60.jpg) | Group enriched |
PI3 | Peptidase inhibitor 3, skin-derived | Plasma proteins Predicted secreted proteins
| | ![](/images/17737/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/17737/144088_B_5_1_rna_selected_60x60.jpg) | Group enriched |
LYPD3 | LY6/PLAUR domain containing 3 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/41797/88183_B_8_2_rna_selected_60x60.jpg) | Group enriched |
CR2 | Complement component (3d/Epstein Barr virus) receptor 2 | CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/2659/ihc_cell_selected_60x60.jpg) | ![](/images/2659/6600_B_9_3_rna_selected_60x60.jpg) | Group enriched |
FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | Cancer-related genes CD markers Predicted membrane proteins
| | ![](/images/8928/if_selected_60x60.jpg) | | ![](/images/2624/6433_A_9_8_rna_selected_60x60.jpg) | Group enriched |
MS4A1 | Membrane-spanning 4-domains, subfamily A, member 1 | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | | ![](/images/14341/39080_B_8_5_rna_selected_60x60.jpg) | Group enriched |
TRIM29 | Tripartite motif containing 29 | | | | ![](/images_static/rna_center.gif) | ![](/images/20053/46555_B_7_7_rna_selected_60x60.jpg) | Group enriched |
CD19 | CD19 molecule | CD markers Disease related genes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/16110/36118_A_9_1_rna_selected_60x60.jpg) | Group enriched |
FCRLA | Fc receptor-like A | Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/16545/35769_B_7_6_rna_selected_60x60.jpg) | Group enriched |
TMEM79 | Transmembrane protein 79 | Disease related genes Predicted membrane proteins
| | ![](/images/55214/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/55214/129352_B_8_3_rna_selected_60x60.jpg) | Group enriched |
CD72 | CD72 molecule | CD markers Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/2505/6522_A_7_1_rna_selected_60x60.jpg) | Group enriched |
CSTB | Cystatin B (stefin B) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Transporters
| | | ![](/images_static/rna_center.gif) | ![](/images/47320/103192_B_8_6_rna_selected_60x60.jpg) | Group enriched |
HLA-DOB | Major histocompatibility complex, class II, DO beta | Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13846/32452_A_9_7_rna_selected_60x60.jpg) | Group enriched |
TMEM40 | Transmembrane protein 40 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/44165/102041_B_8_8_rna_selected_60x60.jpg) | Group enriched |
TNFRSF13C | Tumor necrosis factor receptor superfamily, member 13C | CD markers Disease related genes Predicted membrane proteins
| | ![](/images/8380/if_selected_60x60.jpg) | ![](/images/3246/ihc_cell_selected_60x60.jpg) | ![](/images/8380/19870_B_8_1_rna_selected_60x60.jpg) | Group enriched |
ZNF750 | Zinc finger protein 750 | Cancer-related genes Disease related genes
| | ![](/images/21573/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/21573/50402_B_8_6_rna_selected_60x60.jpg) | Group enriched |
CXCR5 | Chemokine (C-X-C motif) receptor 5 | CD markers G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42432/123485_A_8_2_rna_selected_60x60.jpg) | Group enriched |
DSG3 | Desmoglein 3 | Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46864/148887_B_4_3_rna_selected_60x60.jpg) | Group enriched |
SERPINB2 | Serpin peptidase inhibitor, clade B (ovalbumin), member 2 | Cancer-related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/15480/35524_A_4_6_rna_selected_60x60.jpg) | Group enriched |
SFN | Stratifin | Cancer-related genes Plasma proteins
| | | ![](/images/6268/ihc_cell_selected_60x60.jpg) | ![](/images/6268/17244_A_2_3_rna_selected_60x60.jpg) | Group enriched |
CCR7 | Chemokine (C-C motif) receptor 7 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/3796/11202_A_9_6_rna_selected_60x60.jpg) | Group enriched |
CLIC3 | Chloride intracellular channel 3 | Plasma proteins Transporters
| | | ![](/images_static/rna_center.gif) | ![](/images/5963/137904_B_8_5_rna_selected_60x60.jpg) | Group enriched |
LTB | Lymphotoxin beta (TNF superfamily, member 3) | Cancer-related genes Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/48884/109189_B_8_4_rna_selected_60x60.jpg) | Group enriched |
S100A7 | S100 calcium binding protein A7 | Cancer-related genes Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images/1453/ihc_cell_selected_60x60.jpg) | ![](/images/33766/101280_B_9_4_rna_selected_60x60.jpg) | Group enriched |
SELL | Selectin L | Cancer-related genes Candidate cardiovascular disease genes CD markers Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/2144/ihc_cell_selected_60x60.jpg) | ![](/images/2144/5972_A_7_7_rna_selected_60x60.jpg) | Group enriched |